Registered Trials

• ISRCTN89951424, NCT04536051

  Phase 3

  Brazil

  Total Enrollment: 10,300

  Official Trial Registration:

  • ISRCTN89951424(Opens in new tab/window)
  • NCT04536051(Opens in new tab/window)

• NCT04516746

  Phase 3

  Argentina, Chile, Colombia, Peru, United States of America

  Total Enrollment: 40,000

  Official Trial Registration:

  • NCT04516746(Opens in new tab/window)

• NCT04540393

  Phase 3

  Russia

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04540393(Opens in new tab/window)

• CTRI/2020/08/027170

  Phase 2/3

  India

  Total Enrollment: 1,600

  Official Trial Registration:

  • CTRI/2020/08/027170(Opens in new tab/window)

• EudraCT 2020-001228-32, NCT04400838

  Phase 2/3

  United Kingdom

  Total Enrollment: 12,450

  Official Trial Registration:

  • EudraCT 2020-001228-32(Opens in new tab/window)
  • NCT04400838(Opens in new tab/window)

• NCT04686773

  Phase 2

  Azerbaijan

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04686773(Opens in new tab/window)

• PACTR202005681895696

  Phase 1/2

  Kenya

  Total Enrollment: 400

  Official Trial Registration:

  • PACTR202005681895696(Opens in new tab/window)

• EudraCT 2020-001072-15, NCT04324606

  Phase 1/2

  United Kingdom

  Total Enrollment: 1,112

  Official Trial Registration:

  • EudraCT 2020-001072-15(Opens in new tab/window)
  • NCT04324606(Opens in new tab/window)

• PACTR202006922165132, NCT04444674

  Phase 1/2

  South Africa

  Total Enrollment: 2,130

  Official Trial Registration:

  • PACTR202006922165132(Opens in new tab/window)
  • NCT04444674(Opens in new tab/window)

• NCT04568031

  Phase 1/2

  Japan

  Total Enrollment: 256

  Official Trial Registration:

  • NCT04568031(Opens in new tab/window)